Question

Difficulty: MediumEndocrinology and Metabolism

A 4444-year-old woman is evaluated in the outpatient clinic due to profound fatigue, generalized muscle cramps, and a 66-kg (13.213.2-lb) weight gain over the past several months. She reports feeling constantly sluggish and relies on multiple blankets at night despite living in a warm environment. Her medical history is significant for a nonfunctioning pituitary macroadenoma treated with transsphenoidal resection and subsequent adjuvant radiotherapy three years ago. Her blood pressure is 105/65105/65 mmHg and pulse is 5454/min. Physical examination demonstrates a puffy face and delayed relaxation of the deep tendon reflexes.

Laboratory TestResultReference Range
Sodium136136 mEq/L136136-145145 mEq/L
Thyroid-stimulating hormone (TSH)1.41.4 μ\muU/mL0.40.4-4.04.0 μ\muU/mL
Free thyroxine (T4)0.40.4 ng/dL0.90.9-1.71.7 ng/dL

Before initiating targeted pharmacotherapy for her thyroid abnormalities, which of the following is the most appropriate next step in management?

  1. Measurement of early morning serum cortisolAnswer
  2. B
    Initiation of oral levothyroxine therapy
  3. C
    Measurement of anti-thyroid peroxidase antibodies
  4. D
    Measurement of serum reverse triiodothyronine
  5. E
    Initiation of intravenous hydrocortisone

Answer

Measurement of early morning serum cortisol
This patient presents with classic clinical signs of hypothyroidism (fatigue, weight gain, bradycardia, delayed deep tendon reflexes) and laboratory findings consistent with central hypothyroidism (low Free T4 with an inappropriately normal TSH). Given her history of a pituitary macroadenoma treated with transsphenoidal surgery and radiation, she is at high risk for panhypopituitarism, which includes central adrenal insufficiency (ACTH deficiency).

When a patient requires thyroid hormone replacement but has concurrent (or suspected) adrenal insufficiency, the adrenal axis must be evaluated and treated with glucocorticoids FIRST. Initiating levothyroxine increases the basal metabolic rate and accelerates the hepatic clearance of cortisol. In a patient with compromised adrenal reserve who cannot mount a compensatory cortisol response, starting levothyroxine can precipitate a life-threatening acute adrenal crisis. Therefore, measuring early morning serum cortisol is the most critical next step.

Step-by-Step Solution

1
Interpret the thyroid function tests.
The patient has a low Free T4 with an inappropriately normal TSH, indicating central (secondary) hypothyroidism.
In primary hypothyroidism, a low Free T4 would normally stimulate the pituitary to secrete high levels of TSH. A normal or low TSH implies hypothalamic-pituitary axis failure.
2
Identify the underlying etiology and associated risks.
The patient's history of pituitary irradiation puts her at high risk for panhypopituitarism, meaning multiple pituitary hormone deficiencies are likely present, including adrenocorticotropic hormone (ACTH).
Radiation damage to the pituitary can cause progressive failure of anterior pituitary hormone secretion over months to years.
3
Determine the necessary safety check before treating the hypothyroidism.
The adrenal axis must be evaluated with a morning serum cortisol level (or ACTH stimulation test) before initiating thyroid hormone replacement.
Thyroid hormone increases the basal metabolic rate and hepatic clearance of cortisol. If a patient with central adrenal insufficiency is given levothyroxine without glucocorticoid coverage, the sudden increased clearance of cortisol can precipitate a fatal adrenal crisis.

Key Concept

In patients with suspected panhypopituitarism or central hypothyroidism, the hypothalamic-pituitary-adrenal axis must be evaluated for concurrent adrenal insufficiency before initiating levothyroxine therapy to avoid precipitating an acute adrenal crisis.
Rate this question